M. Ashraf-Uz-Zaman

Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer.

Ruiwen Zhang, Wei Wang, K. Alviña, 2020, European journal of medicinal chemistry.

Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.

V. Neugebauer, M. S. Sajib, Constantinos M Mikelis, 2022, ACS chemical neuroscience.

Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target “mtFabH” of Mycobacterium tuberculosis

C. B. Mishra, Ashok Kumar, R. Mongre, 2022, Frontiers in Microbiology.

Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure?

C. B. Mishra, R. Mongre, A. Shukla, 2021, International journal of molecular sciences.

Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview

Aditya Bhalerao, L. Cucullo, Constantinos M Mikelis, 2020, Cancers.

Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.

L. Cucullo, M. S. Sajib, Constantinos M Mikelis, 2018, Bioorganic & medicinal chemistry letters.

Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus.

C. B. Mishra, Y. Yao, Yongcheng Song, 2023, Journal of medicinal chemistry.

Discovery, Structure–Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein–Protein Interactions between AF9/ENL and AF4 or DOT1L

Jidong Zhao, S. Nie, Fangrui Wu, 2023, Cancers.